PERFECT MEDICAL1830.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, PERFECT MEDICAL (1830.HK) trades at a P/E of 8.22x, P/B of 3.78x, P/S of 1.53x, and a dividend yield of 11.02%.
Longitudinal percentile comparison: P/E sits at the 13th percentile over the trailing 10Y window (vs. 5th percentile over 3Y); P/B sits at the 23rd percentile over the trailing 10Y window (vs. 14th percentile over 3Y); P/S sits at the 16th percentile over the trailing 10Y window (vs. 10th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 28th percentile within its industry and the 38th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 11.02%, ranking at the 64th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 10.2 points of each other — a consistent signal from both angles. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. PERFECT MEDICAL operates in the Exclusive Chain sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1830 · SEHK: 1830 · 1830
Want the full picture on whether PERFECT MEDICAL (1830.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 8.22 | ||||||
| P/B (MRQ) | 3.78 | ||||||
| P/S (TTM) | 1.53 | ||||||
| Dividend Yield | 11.02% | ||||||
| Buyback + Div Yield | 11.02% |